Boudes Pol F Insider Trades

Insider Trading History

Track insider trading activity for Boudes Pol F. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Director
Holding Value $30.2k 15,000 shares
Last Trade
Sep 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.6k 15,000 shares
$1.64
$2.01
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Medical Officer
Holding Value $155k 65,000 shares
Last Trade
Jan 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 65,000 shares
$1.72
$2.38
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Director
Holding Value $124k 61,676 shares
Last Trade
Sep 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$102k 61,676 shares
$1.66
$2.01
Galectin Therapeutics
Galectin Therapeutics GALT
Director, Chief Medical Officer
Holding Value $119k 50,000 shares
Last Trade
Jan 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$55.5k 50,000 shares
$1.11
$2.38
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Director
Holding Value $101k 50,000 shares
Last Trade
Sep 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$51.5k 50,000 shares
$1.03
$2.01
Galectin Therapeutics
Galectin Therapeutics GALT
Holding Value $119k 50,000 shares
Last Trade
Jan 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$99k 50,000 shares
$1.98
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Medical Officer
Holding Value $238k 100,000 shares
Last Trade
Mar 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$317k 150,000 shares
$2.11
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Chief Medical Officer
Holding Value $714k 300,000 shares
Last Trade
Mar 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$525k 300,000 shares
$1.75
$2.38
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Director
Holding Value $80.4k 40,000 shares
Last Trade
Jan 20, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$142k 40,000 shares
$3.55
$2.01
Cymabay Therapeutics
Cymabay Therapeutics CBAY
Chief Medical Officer
Holding Value $4.49M 138,312 shares
Last Trade
Jan 29, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.17M 138,312 shares
$8.43
$32.48
Cymabay Therapeutics
Cymabay Therapeutics CBAY
Chief Medical Officer
Holding Value $4.06M 125,000 shares
Last Trade
Jan 24, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.46M 125,000 shares
$11.69
$32.48
Cymabay Therapeutics
Cymabay Therapeutics CBAY
Chief Medical Officer
Holding Value $3.25M 100,000 shares
Last Trade
Jan 19, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$172k 100,000 shares
$1.72
$32.48
Cymabay Therapeutics
Cymabay Therapeutics CBAY
Chief Medical Officer
Holding Value $1.36M 42,000 shares
Last Trade
Jan 04, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.3k 21,000 shares
$2.30
$32.48
Cymabay Therapeutics
Cymabay Therapeutics CBAY
Chief Medical Officer
Holding Value $682k 21,000 shares
Last Trade
Dec 30, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$38.2k 21,000 shares
$1.82
$32.48
Cymabay Therapeutics
Cymabay Therapeutics CBAY
Chief Medical Officer
Holding Value $1.75M 54,000 shares
Last Trade
Jan 26, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$57.2k 54,000 shares
$1.06
$32.48
Cymabay Therapeutics
Cymabay Therapeutics CBAY
Chief Medical Officer
Holding Value $2.44M 75,000 shares
Last Trade
Jan 07, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$750k 75,000 shares
$10.00
$32.48
Cymabay Therapeutics
Cymabay Therapeutics CBAY
Chief Medical Officer
Holding Value $2.5M 77,000 shares
Last Trade
Apr 15, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$32.48

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up